BFC Planning »

Arrowhead Pharmaceuticals shares owned by BFC Planning

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by BFC Planning from 13F filings

Historical chart of BFC Planning investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by BFC Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by BFC Planning

Quarter filed Position value Share count Share price at filing
2026-06-30 $12M 150k 81.51

More positions owned by BFC Planning

NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Micron Technology (MU)
Select Sector Spdr Tr St Str Techn Etf (XLK)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Series Trust ST STR PR SP1500 (SPTM)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)

View all positions for BFC Planning

Top funds holding Arrowhead Pharmaceuticals

BlackRock
venBio Select Advisor
FMR
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Norges Bank Investment Management
Invesco
Geode Capital Management
Fred Alger Management
Baker Bros. Advisors
Susquehanna International
Siren
Vestal Point Capital
Deerfield Management Company

View all funds holding Arrowhead Pharmaceuticals